BI 1701963
id:
bi-1701963-195-283525
title:
BI 1701963
text:
BI 1701963 is an investigational drug that blocks KRAS activation by binding to SOS1 proteins. The drug is thought to be effective in cancers with a KRAS mutation. It has been tested in clinical trials alone and in combination with adagrasib.
brand slug:
wiki
category slug:
encyclopedia
description:
original url:
https://en.wikipedia.org/wiki/BI_1701963
date created:
date modified:
2024-03-11T14:02:32Z
main entity:
{"identifier":"Q123676569","url":"https://www.wikidata.org/entity/Q123676569"}
image:
fields total:
13
integrity:
13